Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: A Canadian HIV clinical trials network study

Journal of Clinical Oncology

Volumn 16, Issue 5, 1998, Pages 1736-1742

  Shepherd, Frances A ^a   Beaulieu, Raymond ^a   Gelmon, Karen ^a   Thuot, Claude A ^a   Sawka, Carol ^a   Read, Stanley ^a   Singer, Joel ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; LIVER ENZYME; RECOMBINANT ALPHA2B INTERFERON; ZIDOVUDINE;

ADULT; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLU LIKE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LIVER TOXICITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031803599     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.5.1736     Document Type: Article

References (27)

1. Peters BS, Beck EJ, Coleman DG, et al: Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: The changing face of AIDS. BMJ 302:203-207, 1991
2. Hoover DR, Black C, Jacobson LP, et al: Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 138:266-278, 1993
3. Katz MH, Hessol NA, Buchbinder SP, et al: Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis 170:198-202, 1994
4. Krown SE: Interferon and other biologic agents for the treatment of Kaposi's sarcoma. Hematol Oncol Clin North Am 5:311-322, 1991
5. Mitsuyasu RT: Interferon alfa in the treatment of AIDS-related Kaposi's sarcoma. Br J Haematol 79:69-73, 1991 (suppl 1)
6. Lane HC: The role of interferon in patients with human immunodeficiency virus infections. Semin Oncol 18:46-52. 1991 (suppl 1)
7. Lane HC, Falloun J, Walker RE: Zidovudine in patients with human immunodeficency virus (HIV) infection and Kaposi's sarcoma. Ann Intern Med 11:41-50, 1989
8. H. DeWit R, Reiss P, Bakker PJM: Lack of activity of zidovudine in AIDS-associated Kaposi's sarcoma. AIDS 3:847-850, 1989
9. Hartshorn KL, Vogt MW, Chou T-C: Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alfa interferon. Antimicrob Agents Chemother 31:168-172, 1987
10. Yarchoan R, Mitsuya M, Myers CE, et al: Clinical Pharmacology of 3 <-azido-2 3-dideoxythymidine (zidovodine) and related dideoxythymidine dideoxynucleosides. N Engl J Med 321:726-738, 1989
11. Krown SE, Real FX, Cunningham-Rundles S, et al. Preliminary observations on the effect of recombinant leucocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 308:1071-1076, 1983
12. Kovacs JA, Deyton L, Davey R: Combined zidovudine and interferon therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 111:280-287, 1989
13. Krown SE, Gold JWM, Niedzwiecki D, et al: Interferon with zidovudine: Safety, tolerance, clinical and virologic effects in patients with Kaposi's sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 112:812-821, 1990
14. Fischl MA, Uttamchandani RB, Resnick L, et al: A phase I study of recombinant human interferon alfa-2a or human lymphoblastoid interferon alfa n-1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr 4:1-10, 1991
15. Fischl MA: Antiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma. Am J Med 90:25-75, 1991 (suppl 4A)
16. Kriegel RL, Friedman-Kien AE: Epidemic Kaposi's sarcoma. Semin Oncol 17:350-360, 1990
17. Krown SE, Parades J, Bundow D, et al: Interferon, zidovudine and granulocyte-macrophage colony-stimulating factor: A phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS. J Clin Oncol 10:1344-1351, 1992
18. Gill PS, Rarick MU, Bernstein-Singer M, et al: Interferon alfa maintenance therapy after cytotoxic chemotherapy for treatment acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Biol Res Modifiers 9:512-516, 1990
19. 1-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure. J Acquir Immune Defic Syndr 3:591-600, 1990
20. 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol 11:379-384, 1996
21. Scadden DT, Berring HA, Levine JD, et al: Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. J Clin Oncol 9:802-808, 1991
22. Vogt MW, Durno AG, Chou TC, et al: Synergistic interaction of 2',3' dideoxycytidine and recombinant interferon-α on replication of human immunodeficiency virus type 1. J Infect Dis 158:378-385, 1988
23. Johnson VA, Merrill DP, Videler JA, et al: Two-drug combinations of zidovudine, didanosine, and recombinant interferon-α inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro. J Infect Dis 164:646-655, 1991
24. Kedes DH, Ganem D: Sensitivity of Kaposi's sarcoma-associated herpes virus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 99:2082-2086, 1997
25. Conant MA, Opp KM, Poretz D, et al: Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir. AIDS 11:1300-1301, 1997 (letter)
26. Frissen PHJ, van der Ende ME, Ten Napel CHH, et al: Zidovudine and interferon-α combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection. J Infect Dis 169:1351-1355, 1994
27. deBoer JB, van Dam FSAM, Sprangers MAG, et al: Longitudinal study on the quality of life of symptomatic HIV-infected patients in a trial of zidovudine versus zidovudine and interferon-α. AIDS 7:947-953, 1993